Opus Genetics, Inc., a clinical-stage biopharmaceutical company, develops gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs) and other types of therapies for additional ophthalmic disor...
Leadership
George Magrath M.B.A., M.D., M.S.
CEO & Director
Benjamin R. Yerxa Ph.D.
President & Director
Joseph K. Schachle MBA
Chief Operating Officer
Ashwath Jayagopal M.B.A., Ph.D.
Chief Scientific & Development Officer
Chris Ernst
Chief Technology Officer
Jenny Kobin
Investor Relations Officer
Bernhard Hoffmann M.B.A.
Senior Vice President of Corporate Development & Secretary
Amy Zaremba Rabourn C.P.A., MAcc
Head of Financial Quality Assurance
Bindu Manne
Head of Market Development & Commercialization
Sally Tucker Ph.D.
Chief Medical Officer & Senior Vice President of Clinical Development
